Update
SkyePharma considering cuts at Muttenz; leases lab space to Aenova
Drug delivery tech firm SkyePharma has started reviewing operations at its facility in Muttenz, Switzerland in a move that could results in significant job cuts.
Archives for January 10, 2012
Long-term relationship key to Icon’s Shire deal
A prior relationship rather than price was the most significant factor in helping Icon win its strategic deal with Shire according to an analyst who says such a trend is good for the sector.
Bioligands bought by investors and UK's Bridge BioResearch
Preclinical molecular biology services firm BioLigands has changed ownership.
AMRI mulls Hungary chemistry site's future
AMRI has begun reviewing its chemistry services operation in Hungary and says it may cut jobs and shift work to other facilities.
Xoma cuts manufacturing costs to ramp-up R&D
Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.
Sigma-Aldrich to offer start to finish bio-testing thanks to BioReliance takeover
Sigma-Aldrich says it is a step closer to becoming a one-stop-shop for biopharmas in the drug discovery process after it inked a takeover agreement with biological testing firm BioReliance.
Charles River considering sale, media report claims
Charles River is reportedly considering selling the business, with private equity and rival companies believed to be possible buyers.
Zhongxi Sunve buys stake in Chinese oncology API business
Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.
US fake drug seizures up 200%
The value of counterfeit pharmaceuticals seized at US borders jumped 200 per cent in 2011 as enforcement actions took effect.
MonoSol and Midatech form new nanoparticle-film delivery tech JV
Delivery tech firm MonoSol Rx and nanoparticle excipient developer Midatech have set up a new diabetes-focused joint venture (JV).